Vanguard Capital Management
MBOT icon

Vanguard Capital Management’s Microbot Medical MBOT Stock Holding History

Vanguard Capital Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.47M Sell
2,893,717
-13,093
-0.5% -$21.1K ﹤0.01% 3195
2026
Q2 		$5.67M Sell
2,906,810
-2,715
-0.1% -$5.54K ﹤0.01% 3074
2026
Q1 		$7.01M Buy
+2,909,525
New +$6.5M ﹤0.01% 2921

Other funds holding MBOT

Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $38B AUM 25.01% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $121B AUM 21.47% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
AlphaCentric Advisors
AlphaCentric Advisors San Juan, Puerto Rico $113M AUM 27.37% 1-Year Est. Return

Vanguard Capital Management's MBOT Position: Q3 2026 in Review

Vanguard Capital Management reduced its Microbot Medical (MBOT) stake by 0.45% in Q3 2026, selling an estimated $21.1K and leaving 2,893,717 shares worth $3.47M. The position accounts for ﹤0.01% of the portfolio, ranked #3195.

Vanguard Capital Management first reported a position in MBOT in Q1 2026 and has held it in 3 quarters since. The position peaked at $7.01M in Q1 2026. 61 funds tracked by Wall St. Rank hold MBOT as of Q3 2026.

  • Vanguard Capital Management held 2,893,717 shares of Microbot Medical worth $3.47M as of Q3 2026.
  • Vanguard Capital Management sold 13,093 Microbot Medical shares in Q3 2026, an estimated $21.1K.
  • Microbot Medical made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3195 holding.
  • Vanguard Capital Management first reported a position in Microbot Medical in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Microbot Medical position peaked at $7.01M in Q1 2026.
  • 61 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.